302 related articles for article (PubMed ID: 24441388)
41. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2.
Toyoki D; Shibata S; Kuribayashi-Okuma E; Xu N; Ishizawa K; Hosoyamada M; Uchida S
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F826-F834. PubMed ID: 28679589
[TBL] [Abstract][Full Text] [Related]
42. Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients.
Nakashima A; Ichida K; Ohkido I; Yokoyama K; Matsuo H; Ohashi Y; Takada T; Nakayama A; Suzuki H; Shinomiya N; Urashima M; Yokoo T
Hum Cell; 2020 Jul; 33(3):559-568. PubMed ID: 32180207
[TBL] [Abstract][Full Text] [Related]
43. Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout.
Qi H; Sun M; Terkeltaub R; Merriman TR; Chen H; Li Z; Ji A; Xue X; Sun W; Wang C; Li X; He Y; Cui L; Dalbeth N; Li C
Arthritis Rheumatol; 2024 Jul; 76(7):1130-1140. PubMed ID: 38412854
[TBL] [Abstract][Full Text] [Related]
44. The Role of the Intestine in the Development of Hyperuricemia.
Yin H; Liu N; Chen J
Front Immunol; 2022; 13():845684. PubMed ID: 35281005
[TBL] [Abstract][Full Text] [Related]
45. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
46. Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2.
Ristic B; Sivaprakasam S; Narayanan M; Ganapathy V
Biochem J; 2020 Apr; 477(8):1499-1513. PubMed ID: 32239172
[TBL] [Abstract][Full Text] [Related]
47. A novel mouse model of hyperuricemia expressing a human functional ABCG2 variant.
Köttgen A; Köttgen M
Kidney Int; 2021 Jan; 99(1):12-14. PubMed ID: 33390224
[No Abstract] [Full Text] [Related]
48. NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout.
Chiba T; Matsuo H; Kawamura Y; Nagamori S; Nishiyama T; Wei L; Nakayama A; Nakamura T; Sakiyama M; Takada T; Taketani Y; Suma S; Naito M; Oda T; Kumagai H; Moriyama Y; Ichida K; Shimizu T; Kanai Y; Shinomiya N
Arthritis Rheumatol; 2015 Jan; 67(1):281-7. PubMed ID: 25252215
[TBL] [Abstract][Full Text] [Related]
49. An update on the genetic architecture of hyperuricemia and gout.
Merriman TR
Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
[TBL] [Abstract][Full Text] [Related]
50. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.
Matsuo H; Ichida K; Takada T; Nakayama A; Nakashima H; Nakamura T; Kawamura Y; Takada Y; Yamamoto K; Inoue H; Oikawa Y; Naito M; Hishida A; Wakai K; Okada C; Shimizu S; Sakiyama M; Chiba T; Ogata H; Niwa K; Hosoyamada M; Mori A; Hamajima N; Suzuki H; Kanai Y; Sakurai Y; Hosoya T; Shimizu T; Shinomiya N
Sci Rep; 2013; 3():2014. PubMed ID: 23774753
[TBL] [Abstract][Full Text] [Related]
51. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.
Woodward OM; Tukaye DN; Cui J; Greenwell P; Constantoulakis LM; Parker BS; Rao A; Köttgen M; Maloney PC; Guggino WB
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5223-8. PubMed ID: 23493553
[TBL] [Abstract][Full Text] [Related]
52. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
[TBL] [Abstract][Full Text] [Related]
53. ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.
Cleophas MC; Joosten LA; Stamp LK; Dalbeth N; Woodward OM; Merriman TR
Pharmgenomics Pers Med; 2017; 10():129-142. PubMed ID: 28461764
[TBL] [Abstract][Full Text] [Related]
54. Alistipes indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate hyperuricemia.
Xu YX; Liu LD; Zhu JY; Zhu SS; Ye BQ; Yang JL; Huang JY; Huang ZH; You Y; Li WK; He JL; Xia M; Liu Y
Cell Host Microbe; 2024 Mar; 32(3):366-381.e9. PubMed ID: 38412863
[TBL] [Abstract][Full Text] [Related]
55. Functional non-synonymous variants of ABCG2 and gout risk.
Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
[TBL] [Abstract][Full Text] [Related]
56. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
Fujita K; Yamada H; Iijima M; Ichida K
PLoS One; 2019; 14(12):e0226918. PubMed ID: 31891613
[TBL] [Abstract][Full Text] [Related]
57. Regulation of uric acid excretion by the kidney.
Lipkowitz MS
Curr Rheumatol Rep; 2012 Apr; 14(2):179-88. PubMed ID: 22359229
[TBL] [Abstract][Full Text] [Related]
58. [Historical review of gout and hyperuricemia investigations].
Nakamura T
Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
[TBL] [Abstract][Full Text] [Related]
59. Genetics of gout.
Choi HK; Zhu Y; Mount DB
Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
[TBL] [Abstract][Full Text] [Related]
60. Genetics of hyperuricemia and gout: implications for the present and future.
George RL; Keenan RT
Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
